Human case of H3N2 swine flu – false alarm or timely heads-up?
This article was originally published in Clinica
Executive Summary
Confirmation of a case of swine-originated H3N2 influenza – which is common in pigs, but rare in humans – has been officially dismissed as insignificant epidemiologically and unrelated to the H1N1 pandemic. However, it does highlight the need for tight virological surveillance, such as to monitor potential mutations or recombination of viruses. The case was confirmed in Kansas, US, the local KAKE News network reported yesterday. It quotes state and national health officials as dismissing any link to the novel H1N1 strain, and the fact that "most animal-originated infections do not result in human-to-human transmission". A rise in the number of such cases – reportedly 14 in the US so far this year, compared to around one per year, normally – is being attributed to tighter monitoring of H1N1 influenza.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.